Beyond the Autoinjector: Engineering and Formulation Tradeoffs in the Transition to On-Body Delivery

Session details:

• Comparative analysis of large-volume delivery modalities — multiple injections, high-viscosity autoinjectors, large-volume autoinjectors, and on-body injectors — evaluating tradeoffs across formulation, engineering, human factors, sustainability, and cost
• How on-body injector platforms can relieve formulation and engineering constraints for high-dose biologics, and where human factors, sustainability, and cost of goods considerations must be addressed early in development
• Introducing the TxSphere technology that meets the engineering and formulation challenges in a patient centric form factor offering a sustainable solution at a lower cost of goods